Familial Shar-Pei Fever causes recurrent high fevers and swollen hocks. Chronic inflammation accumulates amyloid causing organ damage. Welfare management reduces episode frequency and long-term harm.
FSF episodes cause acute, significant welfare harm. The combination of high fever and painful hock swelling causes obvious distress — affected Shar-Peis may cry, refuse to walk, become anorexic, and show behavioral signs of pain during episodes. The 24-36 hour duration of episodes means they are not brief welfare events but sustained periods of significant suffering that occur repeatedly throughout the dog's life.
The long-term welfare consequence of repeated episodes is amyloid deposition in solid organs. Amyloid accumulates in kidneys — causing progressive renal failure — and liver in many FSF-affected dogs. This systemic amyloidosis represents the most serious long-term welfare concern, ultimately causing organ failure and death earlier than normal life expectancy.
Colchicine prevents acute episodes and reduces amyloid deposition — it is welfare-protective on both counts. Early initiation before amyloid accumulates provides the greatest benefit. Anti-inflammatory treatment (NSAIDs) during episodes reduces the acute welfare burden. Genetic screening could eventually reduce FSF prevalence through informed breeding decisions.